Sunder-Plassmann, G <br/><br/>
Safety aspects of parenteral iron in patients with end-stage renal disease.  [electronic resource] 

 -  Drug safety  Oct 1997 
 - 241-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0114-5916 
<br/><br/><label>Standard No.: </label>10.2165/00002018-199717040-00004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia, Iron-Deficiency--drug therapy<br/>Citric Acid--administration & dosage<br/>Drug Combinations<br/>Drug Monitoring<br/>Erythropoietin--therapeutic use<br/>Ferric Compounds--administration & dosage<br/>Ferric Oxide, Saccharated<br/>Ferrous Compounds--administration & dosage<br/>Glucaric Acid<br/>Humans<br/>Infusions, Intravenous<br/>Injections, Intravenous<br/>Iron Compounds--administration & dosage<br/>Iron Overload--complications<br/>Iron-Dextran Complex--administration & dosage<br/>Kidney Failure, Chronic--complications<br/>Sorbitol--administration & dosage